Aysha S. Ansari
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia.
Journal: Acta biomaterialia
Published: June 27, 2024
Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems.
Journal: Molecular pharmaceutics
Published: January 31, 2024
Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 20, 2023
Multiple gene knockdown strategies for investigating the properties of human leukemia stem cells and exploring new therapies.
Journal: Methods in cell biology
Published: August 11, 2022
Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
Journal: Investigational new drugs
Published: May 27, 2022
Investigation of water-insoluble hydrophobic polyethylenimines as RNAi vehicles in chronic myeloid leukemia therapy.
Journal: Journal of biomedical materials research. Part A
Published: January 19, 2021
At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids.
Journal: Frontiers in bioengineering and biotechnology
Published: March 20, 2019
Biomaterials for polynucleotide delivery to anchorage-independent cells.
Journal: Journal of materials chemistry. B
Published: September 21, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026